glp-1 news today 2025-10-16 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Who Gets the Shot? GLP-1

Meierhofer et al

E.LaiS.OSheaA.CraggsJ

Analysis of nearly 8,000 adults found 45% keep the weight off after one year As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings

Hormone-sensitive conditions Breast cancer history: Consult oncologist before GH peptides Estrogen-related concerns BPC-157, GHK-Cu generally safe Individual assessment needed Uterine fibroids: GH peptides may affect (theoretical) Monitor if using BPC-157 safe Weight loss peptides safe Thyroid issues: Common in women 40+ Peptides generally compatible with thyroid meds Monitor thyroid function Some peptides may help thyroid Combining with HRT/bioidentical hormones Can you use both peptides and HRT